Arteris (NASDAQ:AIP - Get Free Report) was upgraded by Roth Capital to a "strong-buy" rating in a report released on Tuesday, Marketbeat reports.
Several other analysts also recently issued reports on the stock. Northland Securities set a $38.00 price target on shares of Arteris in a report on Wednesday, May 13th. Rosenblatt Securities raised their price objective on shares of Arteris from $20.00 to $38.00 and gave the stock a "buy" rating in a research note on Wednesday, May 13th. Jefferies Financial Group lifted their price objective on Arteris from $16.00 to $35.00 and gave the stock a "hold" rating in a research report on Wednesday, May 13th. TD Cowen upped their target price on shares of Arteris from $22.00 to $40.00 and gave the company a "buy" rating in a report on Wednesday, May 13th. Finally, Oppenheimer began coverage on Arteris in a research report on Thursday, July 16th. They issued an "outperform" rating and a $40.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $38.50.
Check Out Our Latest Stock Analysis on AIP
Arteris Stock Up 6.6%
AIP opened at $32.09 on Tuesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $1.48 billion, a price-to-earnings ratio of -40.62 and a beta of 1.96. Arteris has a one year low of $8.42 and a one year high of $50.26. The business's fifty day moving average is $36.29 and its two-hundred day moving average is $25.97.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million during the quarter, compared to analysts' expectations of $21.03 million. Analysts anticipate that Arteris will post -0.6 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CFO Nicholas B. Hawkins sold 221,035 shares of the business's stock in a transaction on Friday, May 15th. The shares were sold at an average price of $33.40, for a total transaction of $7,382,569.00. Following the transaction, the chief financial officer directly owned 110,600 shares of the company's stock, valued at approximately $3,694,040. The trade was a 66.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 192,686 shares of the company's stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $36.32, for a total transaction of $6,998,355.52. Following the completion of the transaction, the insider directly owned 8,555,047 shares of the company's stock, valued at approximately $310,719,307.04. The trade was a 2.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 1,364,949 shares of company stock worth $48,244,576. Company insiders own 23.30% of the company's stock.
Hedge Funds Weigh In On Arteris
Institutional investors and hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC bought a new position in Arteris during the 1st quarter valued at $1,621,000. Strs Ohio bought a new position in Arteris during the 1st quarter worth $104,000. Geode Capital Management LLC grew its position in shares of Arteris by 4.8% during the second quarter. Geode Capital Management LLC now owns 652,754 shares of the company's stock worth $6,222,000 after acquiring an additional 30,018 shares during the last quarter. Rhumbline Advisers grew its position in Arteris by 35.8% in the 2nd quarter. Rhumbline Advisers now owns 54,416 shares of the company's stock worth $519,000 after purchasing an additional 14,350 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Arteris by 8.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company's stock worth $3,053,000 after buying an additional 25,448 shares in the last quarter. 64.36% of the stock is currently owned by hedge funds and other institutional investors.
About Arteris
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.